Crossmark

Cardiovascular Risk and Blood Pressure Control in Patients with Diabetes at Federally Qualified Health Centers: Baseline Findings from the Office-GAP IMPACT (Office-Guidelines Applied to Practice Improving Diabetic Patients’ Adherence to Treatment and Prevention of Cardiovascular Disease) Program

Crossref DOI link: https://doi.org/10.1007/s40615-026-03143-3

Published Online: 2026-08-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Efeovbokhan, Nephertiti https://orcid.org/0000-0001-8262-2003
Kelly-Blake, Karen https://orcid.org/0000-0002-7629-9219
Perkins, Denise White https://orcid.org/0000-0003-1868-2161
Luo, Zhehui https://orcid.org/0000-0001-9193-3380
Olomu, Adesuwa https://orcid.org/0000-0002-8244-9308
Funding

Funding for this research was provided by:

National Heart, Lung, and Blood Institute (RO1 HL149777-01A1)
License Information

Text and Data Mining valid from 2026-08-05

Version of Record valid from 2026-08-05
More Information

Article History

Received: 28 December 2025

Revised: 3 June 2026

Accepted: 15 July 2026

First Online: 5 August 2026

Declarations

Consent to participate: Written informed consent was obtained from all individual participants included in the study.

Ethics approval: The Michigan State University Biomedical and Health Institutional Review Board approved the study, MSU Study ID: STUDY00004464.

Competing interests: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below